Literature DB >> 23870535

Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.

Lenka Fialová1, Ales Bartos, Jana Svarcová, Denisa Zimova, Jolana Kotoucova, Ivan Malbohan.   

Abstract

A release of light neurofilament subunits (NFL) into cerebrospinal fluid (CSF) and serum in multiple sclerosis (MS) may induce an immune response. We examined CSF and serum NFL levels and IgG antibodies against NFL in 19 patients with a clinically isolated syndrome (CIS) early converted into MS, 20 CIS-non-converters, 23 MS patients and 32 controls. CSF NFL levels were significantly higher in all patient groups. The highest CSF or intrathecally (IT) synthesized anti-NFL antibodies and CSF/serum ratios of anti-NFL antibodies were observed in CIS-converters. CSF NFL and CSF or IT anti-NFL antibodies could be surrogate biomarkers of axonal injury in early MS.
© 2013.

Entities:  

Keywords:  Antibody; Cerebrospinal fluid; Clinically isolated syndrome; Light neurofilament subunit; Multiple sclerosis; Serum

Mesh:

Substances:

Year:  2013        PMID: 23870535     DOI: 10.1016/j.jneuroim.2013.06.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

Review 1.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

2.  Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

Authors:  Jacqueline R Rivas; Sara J Ireland; Rati Chkheidze; William H Rounds; Joseph Lim; Jordan Johnson; Denise M O Ramirez; Ann J Ligocki; Ding Chen; Alyssa A Guzman; Mark Woodhall; Patrick C Wilson; Eric Meffre; Charles White; Benjamin M Greenberg; Patrick Waters; Lindsay G Cowell; Ann M Stowe; Nancy L Monson
Journal:  Acta Neuropathol       Date:  2016-10-11       Impact factor: 17.088

3.  Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy.

Authors:  Asuman Celikbilek; Nermin Tanik; Seda Sabah; Elif Borekci; Lutfi Akyol; Hakan Ak; Mehmet Adam; Murat Suher; Neziha Yilmaz
Journal:  Mol Biol Rep       Date:  2014-04-15       Impact factor: 2.316

Review 4.  Drug Treatment of Clinically Isolated Syndrome.

Authors:  Moritz Förster; Jonas Graf; Jan Mares; Orhan Aktas; Hans-Peter Hartung; David Kremer
Journal:  CNS Drugs       Date:  2019-07       Impact factor: 6.497

Review 5.  Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-03       Impact factor: 2.570

Review 6.  The Cerebrospinal Fluid in Multiple Sclerosis.

Authors:  Florian Deisenhammer; Henrik Zetterberg; Brit Fitzner; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

7.  Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.

Authors:  Sarah-Jane Martin; Sarah McGlasson; David Hunt; James Overell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-05-23       Impact factor: 13.654

8.  Antibodies to neurofilament light as potential biomarkers in multiple sclerosis.

Authors:  Fabiola Puentes; Pascal Benkert; Sandra Amor; Jens Kuhle; Gavin Giovannoni
Journal:  BMJ Neurol Open       Date:  2021-11-11

9.  Neurofilament light chain level is a weak risk factor for the development of MS.

Authors:  Georgina Arrambide; Carmen Espejo; Herena Eixarch; Luisa M Villar; José C Alvarez-Cermeño; Carmen Picón; Jens Kuhle; Giulio Disanto; Ludwig Kappos; Jaume Sastre-Garriga; Deborah Pareto; Eva Simon; Manuel Comabella; Jordi Río; Carlos Nos; Carmen Tur; Joaquín Castilló; Angela Vidal-Jordana; Ingrid Galán; Maria J Arévalo; Cristina Auger; Alex Rovira; Xavier Montalban; Mar Tintore
Journal:  Neurology       Date:  2016-08-12       Impact factor: 9.910

10.  Paraneoplastic neuronal intermediate filament autoimmunity.

Authors:  Eati Basal; Nicholas Zalewski; Thomas J Kryzer; Shannon R Hinson; Yong Guo; Divyanshu Dubey; Eduardo E Benarroch; Claudia F Lucchinetti; Sean J Pittock; Vanda A Lennon; Andrew McKeon
Journal:  Neurology       Date:  2018-10-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.